title: Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy.
authors.affiliation: University of Minnesota, Minneapolis 55455.
authors.forename: D M
authors.initials: DM
authors.lastname: Canafax
authors.forename: B C
authors.initials: BC
authors.lastname: Carleton
authors.forename: A J
authors.initials: AJ
authors.lastname: Matas
authors.forename: W D
authors.initials: WD
authors.lastname: Payne
authors.forename: D L
authors.initials: DL
authors.lastname: Dunn
authors.forename: D E
authors.initials: DE
authors.lastname: Sutherland
authors.forename: J S
authors.initials: JS
authors.lastname: Najarian
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000628:therapy; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics*; D016030:Kidney Transplantation / Q000191:economics* / Q000276:immunology*; D007902:Length of Stay; D011241:Prednisone / Q000627:therapeutic use; D016019:Survival Analysis; D014481:United States
chemical_list: D000961:Antilymphocyte Serum; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone